scholarly journals Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)

2010 ◽  
Vol 149 (3) ◽  
pp. 376-382 ◽  
Author(s):  
Sergio Amadori ◽  
Stefan Suciu ◽  
Dominik Selleslag ◽  
Roberto Stasi ◽  
Giuliana Alimena ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Randomized Trial ◽  
Myeloid Leukaemia ◽  
Older Patients ◽  
Low Dose ◽  
Phase Ii Study ◽  
Gemtuzumab Ozogamicin ◽  
Intensive Chemotherapy ◽  
Newly Diagnosed ◽  
Acute Myeloid

scholarly journals Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS

2015 ◽  
Vol 172 (2) ◽  
pp. 238-245 ◽  
Author(s):  
Raya Mawad ◽  
Pamela S. Becker ◽  
Paul Hendrie ◽  
Bart Scott ◽  
Brent L. Wood ◽  
...  
Keyword(s):  
High Risk ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Phase Ii ◽  
Older Patients ◽  
Phase Ii Study ◽  
Newly Diagnosed ◽  
Acute Myeloid

scholarly journals Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis

2013 ◽  
Vol 163 (3) ◽  
pp. 315-325 ◽  
Author(s):  
Mohamed A. Kharfan-Dabaja ◽  
Mehdi Hamadani ◽  
Tea Reljic ◽  
Rachel Pyngolil ◽  
Rami S. Komrokji ◽  
...  
Keyword(s):  
Systematic Review ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Meta Analysis ◽  
Gemtuzumab Ozogamicin ◽  
Newly Diagnosed ◽  
Acute Myeloid

A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia

Leukemia ◽  
2015 ◽  
Vol 29 (6) ◽  
pp. 1312-1319 ◽  
Author(s):  
A K Burnett ◽  
N Russell ◽  
R K Hills ◽  
N Panoskaltsis ◽  
A Khwaja ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Nucleoside Analogue ◽  
Older Patients ◽  
Low Dose ◽  
The Novel ◽  
Low Dose Cytarabine ◽  
Acute Myeloid

scholarly journals Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial

2019 ◽  
Vol 6 (1) ◽  
pp. e29-e37 ◽  
Author(s):  
Nicholas J Short ◽  
Hagop M Kantarjian ◽  
Sanam Loghavi ◽  
Xuelin Huang ◽  
Wei Qiao ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Older Patients ◽  
Phase 2 ◽  
Newly Diagnosed ◽  
Phase 2 Trial ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document